Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net Loss	$ (5,684,222)	$ (4,816,150)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	39,351	26,011
Unrealized gain on marketable securities	(33,403)
Stock-based compensation	3,339,187	3,375,903
Gain on PPP loan forgiveness		(250,000)
Non-cash lease expense	29,011	29,011
Changes in operating assets and liabilities:
Accounts receivable		(11,000)
Prepaid assets and other current assets	(29,972)	(104,099)
Accounts payable	(78,316)	163,067
Accrued expenses and other current liabilities	102,912	21,067
Lease liability	(33,288)	(28,444)
Net cash used in operating activities	(2,348,740)	(1,594,634)
Cash flows from investing activities:
Sale of marketable securities	2,568,654
Purchases of equipment	(60,022)	(109,573)
Net cash provided by (used in) investing activities	2,508,632	(109,573)
Cash flows from financing activities:
Net cash used in financing activities
Net increase (decrease) in cash and cash equivalents	159,892	(1,704,207)
Cash and cash equivalents - beginning of period	1,676,577	21,026,727
Cash and cash equivalents - end of period	$ 1,836,469	$ 19,322,520